HUTCHMED (China) Ltd (HCM) income statement
HCMNasdaqPharmaceutical PreparationsAlso trades as HMDCF
Số liệu tài chính tới năm tài chính 2025, năm kết thúc ngày Dec 31, 2025Last filing: 20-F on Mar 5, 2026Score 5/30
$13.99−0.41 (-2.85%)
Close on Nov 18, 2026Market cap $2.44BP/E 5.4Yield –
HUTCHMED (China) Ltd income statement
Ratios
Latest available, balances at Jun 30, 2026
Profitability, FY2025
- Gross margin
- 38.7%
- Operating margin
- -7.1%
- Net margin
- 83.3%
- Return on equity, FY2025
- 45.7%
Financial strength
- Current ratio
- 5.64
- Debt to equity
- 0.09
- Debt to assets
- 6.7%
- Cash to current liabilities
- 38.7%
Valuation
- P/E ratio
- 5.4
- Price to sales
- 4.45
- Price to book
- 1.94
- Dividend yield
- –
See a number that looks wrong?